PMID- 20232134 OWN - NLM STAT- MEDLINE DCOM- 20100915 LR - 20191008 IS - 1573-7225 (Electronic) IS - 0957-5243 (Print) IS - 0957-5243 (Linking) VI - 21 IP - 7 DP - 2010 Jul TI - A case-control study of tobacco use and other non-occupational risk factors for lymphoma subtypes defined by t(14; 18) translocations and bcl-2 expression. PG - 1147-54 LID - 10.1007/s10552-010-9531-8 [doi] AB - OBJECTIVE: We re-evaluated reported associations between tobacco use and other factors and non-Hodgkin lymphoma (NHL) t(14; 18)-subtypes based on fluorescence in situ hybridization (FISH) assays believed to be more sensitive than polymerase chain reaction (PCR), previously used for detecting t(14; 18). METHODS: Commercial FISH assays and bcl-2 immunostaining were performed on paraffin sections to determine t(14; 18) and bcl-2 case-subtypes. Polytomous logistic regression models estimated associations between NHL case-subtypes (versus 1,245 population-based controls) and tobacco use as well as other factors. RESULTS: Adjusting for age, state, and proxy status, t(14; 18)-negative NHL was associated with any tobacco use (vs. no tobacco use, OR = 1.9, 95% CI = 1.0-3.5), including current smoking (vs. no cigarette use, OR = 1.9, 95% CI = 1.1-3.2). Tobacco exposures were not clearly associated with t(14; 18)-positive NHL or bcl-2 case-subtypes. Hair-dye use and family history of a hemolymphatic cancer were associated with t(14; 18)-negative NHL, but the number of exposed cases was small. CONCLUSIONS: The association between t(14; 18)-negative NHL and cigarette smoking was unexpected given previous evidence of associations between smoking and follicular lymphoma (which is largely t(14; 18)-positive). Future studies characterizing additional molecular characteristics of t(14; 18)-negative NHL may help determine whether the association with smoking may have been causal versus an artifact of chance or bias. FAU - Chang, Cindy M AU - Chang CM AD - Infections and Immunoepidemiology Branch, National Cancer Institute, Rockville, MD, USA. changcm@mail.nih.gov FAU - Schroeder, Jane C AU - Schroeder JC FAU - Olshan, Andrew F AU - Olshan AF FAU - Dunphy, Cherie H AU - Dunphy CH FAU - Huang, Wen-Yi AU - Huang WY FAU - Baric, Ralph S AU - Baric RS FAU - Conway, Kathleen AU - Conway K FAU - Cerhan, James R AU - Cerhan JR FAU - Lynch, Charles F AU - Lynch CF FAU - Rothman, Nathaniel AU - Rothman N FAU - Cantor, Kenneth P AU - Cantor KP FAU - Blair, Aaron AU - Blair A LA - eng GR - P30 ES010126/ES/NIEHS NIH HHS/United States GR - R24 HD050924/HD/NICHD NIH HHS/United States GR - R03 CA71617-01/CA/NCI NIH HHS/United States GR - Z01 CP010119-12/Intramural NIH HHS/United States GR - P30ES10126/ES/NIEHS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, N.I.H., Intramural PT - Research Support, Non-U.S. Gov't DEP - 20100316 PL - Netherlands TA - Cancer Causes Control JT - Cancer causes & control : CCC JID - 9100846 RN - 0 (Proto-Oncogene Proteins c-bcl-2) SB - IM MH - Adult MH - Case-Control Studies MH - Chromosomes, Human, Pair 14 MH - Chromosomes, Human, Pair 18 MH - Humans MH - Immunohistochemistry MH - In Situ Hybridization, Fluorescence MH - Incidence MH - Iowa/epidemiology MH - Logistic Models MH - Lymphoma, Non-Hodgkin/*epidemiology/genetics/metabolism MH - Male MH - Middle Aged MH - Minnesota/epidemiology MH - Proto-Oncogene Proteins c-bcl-2/*analysis MH - Risk Factors MH - *Smoking MH - Translocation, Genetic/*genetics PMC - PMC3052629 MID - NIHMS272424 EDAT- 2010/03/17 06:00 MHDA- 2010/09/16 06:00 PMCR- 2011/07/01 CRDT- 2010/03/17 06:00 PHST- 2009/10/07 00:00 [received] PHST- 2010/02/25 00:00 [accepted] PHST- 2010/03/17 06:00 [entrez] PHST- 2010/03/17 06:00 [pubmed] PHST- 2010/09/16 06:00 [medline] PHST- 2011/07/01 00:00 [pmc-release] AID - 10.1007/s10552-010-9531-8 [doi] PST - ppublish SO - Cancer Causes Control. 2010 Jul;21(7):1147-54. doi: 10.1007/s10552-010-9531-8. Epub 2010 Mar 16.